Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
G. d'Annunzio University
ClinicalTrials.gov Identifier:
NCT00565500
First received: November 29, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2005
  Estimated Primary Completion Date: No date given